CysHHC10

CAS No. 1408311-03-4

CysHHC10 ( )

Catalog No. M30362 CAS No. 1408311-03-4

CysHHC10 is a synthetic antimicrobial peptide (AMP), and exhibits strong anti-microbial properties against both Gram-positive and Gram-negative bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    CysHHC10
  • Note
    Research use only, not for human use.
  • Brief Description
    CysHHC10 is a synthetic antimicrobial peptide (AMP), and exhibits strong anti-microbial properties against both Gram-positive and Gram-negative bacteria.
  • Description
    CysHHC10 is a synthetic antimicrobial peptide (AMP), and exhibits strong anti-microbial properties against both Gram-positive and Gram-negative bacteria.
  • Synonyms
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    MIC: 10.1 mM (E. coli), 20.2 mM (P. aeruginosa), 2.5 mM (S. aureus) and 1.3 mM (S. aureus)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1408311-03-4
  • Formula Weight
    1546.9
  • Molecular Formula
    C77H107N23O10S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Li NN, et al. An antimicrobial peptide with an aggregation-induced emission (AIE) luminogen for studying bacterial membrane interactions and antibacterial actions. Chem Commun (Camb). 2017 Mar 16;53(23):3315-3318.
molnova catalog
related products
  • Dup-721

    DuP-721 is a broad spectrum and orally active antibacterial agent against a variety of clinically susceptible and resistant bacteria, especially M. tuberculosis.

  • Cephalexin

    Cefalexin is a cephalosporin antibiotic.

  • Ribocil

    Ribocil is a synthetic mimic of riboflavin 5’-monophosphate (FMN) that competes with the natural ligand to inhibit FMN riboswitch-mediated expression of ribB.